|Safety Data Sheet
||Circuit Frame/Bonding Film|
CircuitMedic, 22 Parkridge Road, Haverhill, MA 01835 USA
Phone: 978-373-1600 | Website: http://www.circuitmedic.com
CircuitMedic disclaims all liability associated with the use of this information.
|Revision Date: Jun 8, 2016|
Section 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
||Circuit Frame with Bonding Film
||Various Product Numbers
22 Parkridge Road, Haverhill, MA 01835 USA
PHONE: 978-373-1600, FAX: 978-372-5700
||For Chemical Emergency Spill, Leak, Fire, Exposure, or Accident
Call CHEMTREC Day or Night
Within USA and Canada: 1-800-424-9300 CCN4877
Outside USA and Canada: +1 703-527-3887 (collect calls accepted)
Section 2. HAZARD IDENTIFICATION
||Classification according to Regulation(EC)No1272/2008
Classifications applicable to the OSHA GHS Hazard Communication Standard (29CFR1910.1200)
|Potential Health Effects:
||As a part of the hazard assessment process, an industrial hygiene study was conducted to monitor the potential exposure to the off-gases from this product during normal use. Conclusions from the results of these studies indicate that exposure levels during press lamination using adequate ventilation were well below regulated limits (e.g. an order of magnitude below the exposure limit). Tests run for nuisance dust levels also indicated exposure levels well below
regulated limits. As a result of this test data, the potential exposure to the vapors and dusts of this product is minimal.
||Inhalation may cause irritation of the upper respiratory passages, with sneezing, coughing and discomfort; or temporary lung irritation effects with cough, discomfort, difficulty breathing, or shortness of breath.
Inhalation, ingestion or skin contact may cause temporary mild depression of the central nervous system with dizziness, confusion, incoordination or drowsiness followed by an asymptomatic period usually ranging from 12 to 24 hours. There are reports that suggest headache, hearing loss and vertigo (dizziness) in workers exposed to less than 110 ppm of 1-Butanol.
||Eye contact with high concentrations of vapors may cause eye irritation with discomfort, tearing or blurring of vision.
||Skin contact may cause redness of the skin and dermatitis with itching or rash. Evidence from animal testing on some vapor components suggests that skin permeation can occur in
amounts capable of producing the effects of systemic toxicity.
||None of the components present in this material at concentrations equal to or greater than 0.1% are listed by IARC, NTP, OSHA or ACGIH as a carcinogen.
Section 3. COMPOSITION, INFORMATION OR INGREDIENTS
* Disclosure as a toxic chemical is required under Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 and 40 CFR part 372.
||0 - 60%
||0 - 20%
|* Butyl Acrylate
||1 - 5%
||1 - 10%
||0 - 40%
This product is shipped in very small quantities, typically less than 10 square inches. The quantity of vapors is estimated to be 10-15 lbs per 100,000 sq feet of adhesive. Vapor evolution results are based on the percentage of weight loss measured by Thermal Gravimetric Analysis (TGA).
This weight loss includes water vapor. The pounds of vapor are not all "VOC's" as "defined" by the EPA for Clean Air Act purpose.
Section 4. FIRST AID MEASURES
||If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Call a physician.
||In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Call a physician.
||Flush skin with water after contact. Wash contaminated clothing before reuse.
||Ingestion is not considered a potential route of exposure.
Section 5. FIRE-FIGHTING MEASURES
|Flammable limits in Air, % by Volume:
||LEL: not determined UEL: not determined
|Fire Fighting Instructions:
||Evacuate personnel to a safe area. Keep personnel removed and upwind of fire. Wear self-contained breathing apparatus. Runoff from fire control may be a pollution hazard.
||Use media appropriate for surrounding material.
Section 6. ACCIDENTAL RELEASE MEASURES
||Review FIRE FIGHTING MEASURES and HANDLING sections before proceeding with clean-up. Use appropriate PERSONAL PROTECTIVE EQUIPMENT during clean-up.
Section 7. HANDLING AND STORAGE
||Do not breathe vapor or mist. Do not breathe dust. Do not get in eyes. Do not store or consume food, drink or tobacco in areas where they may become contaminated with this material. Good industrial hygiene procedures include washing hands after handling.
||40°F - 85°F.
||Do not store or consume food, drink or tobacco in areas where they may become contaminated with this material.
Section 8. EXPOSURE CONTROLS AND PERSONAL PROTECTION
||Use only with adequate ventilation.
|Personal Protective Equipment:
||Eye/Face:Safety Glasses. Respirator:Use adequate ventilation when cutting or heating.
|Applicable Exposure Limits:
||PEL (OSHA) : 5 ppm, 19 mg/m3, 8 Hr. TWA, Skin
TLV (ACGIH) : 5 ppm, 19 mg/m3, 8 Hr. TWA, Skin, A4
||PEL (OSHA) : 100 ppm, 300 mg/m3
TLV (ACGIH) : 20 ppm, 8 Hr. TWA
||PEL (OSHA) : None Established
TLV (ACGIH) : 2 ppm, 8 Hr. TWA, A4, SEN
||PEL (OSHA) : None Established
TLV (ACGIH) : None EstablishedPEL
||PEL (OSHA) : 269 mg.m3
TLV (ACGIH) : 200 ppm TWA
TLV (ACGIH) : 250 ppm STEL
Section 9. PHYSICAL AND CHEMICAL PROPERTIES
||2.0 wt% water + vapors listed above.
Section 10. STABILITY AND REACTIVITY
||Stable at normal temperatures and storage conditions.
|Incompatibility with Other Materials:
||None reasonably foreseeable.
||Decomposes with heat. See composition information for vapor information.
||Polymerization can occur. Conditions leading to polymerization are heat and pressure.
Section 11. TOXICOLOGICAL INFORMATION
|Results of Component Toxicity Test Performed:
||Information not available.
||Information not available.
Section 12. ECOLOGICAL INFORMATION
||Aquatic Toxicity Insoluble
Section 13. DISPOSAL CONSIDERATIONS
||Treatment, storage, transportation, and disposal must be in accordance with applicable Federal, State/Provincial, and Local regulations. Do not burn.
Section 14. TRANSPORT INFORMATION
||DOT/IMO/IATA Not Regulated.
Section 15. REGULATORY INFORMATION
United States Federal Regulations:
|TSCA Inventory Status
||In compliance with TSCA Inventory requirements for commercial purposes. State Regulations (U.S.) WARNING - SUBSTANCES KNOWN TO THE STATE OF CALIFORNIA TO CAUSE CANCER, BIRTH
|State Regulations (U.S.):
||WARNING - SUBSTANCES KNOWN TO THE STATE OF CALIFORNIA TO CAUSE
CANCER, BIRTH DEFECTS OR OTHER REPRODUCTIVE HARM- Acrylonitrile- <0.02%
Section 16. OTHER INFORMATION
To the best of our knowledge, the information contained herein is accurate. However, neither Circuit Technology Center, Inc., nor any of its subsidiaries assumes any liability whatsoever for the accuracy or completeness of the information contained herein. Final determination of suitability of any material is the sole responsibility of the user. All materials may present unknown hazards and should be used with caution. Although certain hazards are described herein, we cannot guarantee that these are the only hazards which exist.
|European risk and Safety Phrases:
|European Symbols Needed:
|Canadian WHIMS Symbols:
|Abbreviations Used in this Document:
||NE - Not Established, NA - Not Applicable/Not Available, NIF - No Information Found
||Code of Federal Regulations (CFR)
The Sigma-Aldrich Library of Regulatory and Safety Data
Chemical Guide and OSHA Hazard Communication Standard
Various Federal, State & Local Regulations